Announcements Trials

Browse Landscape

Phase

Phase 1/2 5 Phase 1 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Carboplatin 314 Paclitaxel 302 Cisplatin 250 Docetaxel 237 pembrolizumab 230 Gemcitabine 213 Pemetrexed 158 Capecitabine 147 Rituximab 144 Bevacizumab 142 Dexamethasone 125 Fluorouracil 120 Cyclophosphamide 102 Trastuzumab 100 Doxorubicin 96 Nivolumab 92 Prednisone 91 Oxaliplatin 89 atezolizumab 73 Leucovorin 71 durvalumab 69 130-nm albumin-bound paclitaxel 67 Injections 64 Lenalidomide 63 Irinotecan 60 Bortezomib 55 Letrozole 54 Topotecan 53 Fulvestrant 53 Drug Therapy 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Infusions, Intravenous × Clear all

NCT00399035 2016-12-28

HORIZON II

AstraZeneca

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡